HB 1586 makes broad changes to Indiana’s Medicaid financing structure, especially for hospital-related payments. It revises the rules for determining disproportionate share hospitals and other eligible providers, extends the hospital assessment fee authority through June 30, 2027, and adds a new managed care organization assessment fee. The bill also creates new statutory definitions and oversight procedures tied to state directed payment programs, federal CMS approval, and the hospital assessment fee committee.
A major feature of the bill is the creation of a state directed payment framework that would begin after June 30, 2025, for inpatient and outpatient hospital services. Under that framework, hospitals would receive enhanced Medicaid reimbursement through managed care organizations, with the state share funded by hospital fees and, separately, a new fee on managed care organizations. The bill also revises how Medicaid disproportionate share payments are allocated, including a $1,000 payment for certain qualifying acute care hospitals during periods when the directed payment program is in effect, and it adjusts how existing hospital fee revenues and trust funds may be used.
The bill further updates the Healthy Indiana Plan financing provisions to coordinate with the new payment structure. It preserves the plan’s non-entitlement status, maintains conditions under which the plan could be terminated, and ties funding mechanisms to federal approval and the continued availability of matching funds. It also requires the Family and Social Services Administration and related committees to submit and negotiate federal documentation, adopt rules, and perform reconciliations to ensure the new payment and fee structures comply with federal Medicaid requirements.
The overall sentiment reflected in the available legislative history is strongly favorable. The House Public Health Committee reported the bill do pass with an 11-0 vote, and there are no recorded dissenting votes or committee transcript objections in the provided materials. That suggests broad support at the committee stage for the bill’s Medicaid financing changes and its effort to preserve or enhance hospital reimbursement.
No specific points of contention are documented in the provided context, but the bill’s structure indicates likely areas of policy sensitivity: the new managed care assessment fee, the redistribution of Medicaid funding among hospitals and managed care organizations, the reliance on federal CMS approval, and the possibility of pro rata reductions or program termination if federal approval or funding conditions are not met. The bill appears designed to protect hospital reimbursement levels while shifting some financing responsibility to managed care organizations and preserving state flexibility if federal rules change.
HB 1586 would amend multiple sections of the Indiana Code governing Medicaid financing, hospital assessment fees, disproportionate share hospital payments, the Healthy Indiana Plan trust fund, and managed care regulation. It extends the hospital assessment fee chapter to 2027, creates a new managed care assessment fee chapter in Title 27, and authorizes the Office of Medicaid Policy and Planning to implement new state directed payment programs for hospital services, subject to federal approval. The bill also changes payment formulas, eligibility rules, fund uses, reconciliation requirements, and rulemaking obligations for state agencies and committees involved in Medicaid financing.
The available legislative record shows clear support for the bill at the committee level. The House Public Health Committee voted 11-0 to report the bill do pass, and no opposing testimony or recorded dissent is included in the provided materials. The bill’s design suggests it is intended as a technical and fiscal Medicaid financing measure aimed at maintaining hospital reimbursement and federal compliance, which likely contributed to the favorable committee reception.
No explicit controversy is captured in the provided transcripts or vote history, but the bill contains several provisions that could be contentious in practice. These include the new assessment on managed care organizations, the reallocation of Medicaid financing burdens between hospitals and MCOs, and the dependence on CMS approval for both the state directed payment programs and the fee structure. Hospitals, managed care organizations, and state budget officials could have differing views on the fairness and sustainability of the fee formulas, the use of intergovernmental transfers, and the possibility that payments may be reduced or terminated if federal approval is not obtained or if federal matching funds change.